Skip to main content

Day: September 11, 2023

Sosei Heptares’ partner Neurocrine Biosciences Initiates Phase 1 Clinical Study Evaluating Effects of NBI-1117570 in Healthy Adults

NBI-1117570 is an investigational, oral, muscarinic M1/M4 selective dual agonist discovered by Sosei Heptares that may have the potential to treat neurological and neuropsychiatric conditions NBI-1117570 is the second compound to advance into clinical development from a portfolio of selective muscarinic receptor agonists licensed by Sosei Heptares to Neurocrine following NBI-1117568, an oral, selective muscarinic M4 receptor agonist, which is in Phase 2 clinical trials as an investigational treatment for schizophreniaTokyo, Japan and Cambridge, UK, 12 September 2023 – Sosei Group Corporation (“the Company”; TSE: 4565), has been notified by its partner Neurocrine Biosciences Inc. (“Neurocrine”; Nasdaq: NBIX), a leading neuroscience-focused biopharmaceutical company, that it has initiated its Phase 1 first-in-human clinical study to evaluate...

Continue reading

UPDATE — DIRTT Environmental Solutions Ltd.

CALGARY, Alberta, Sept. 11, 2023 (GLOBE NEWSWIRE) — Explanatory Note: Updated below on September 11, 2023 pursuant to Form 8-K/A filed on September 11, 2023 with the SEC to explain the delisting DIRTT to Delist from Nasdaq Exchange; Public Trading on Toronto Stock Exchange Will Continue DIRTT Environmental Solutions Ltd. (“DIRTT” or the “Company”), a leader in industrialized construction, announced on September 6, 2023, that The Nasdaq Stock Market (“Nasdaq”) will be delisting its shares on or around September 15, 2023. After the delisting, all current and future DIRTT shareholders will retain their ability to publicly trade DIRTT shares on the Toronto Stock Exchange (“TSX”) under the symbol “DRT”.  The Company estimates a recurring annual cost savings of approximately USD $400,000 from the delisting. Otherwise, the...

Continue reading

NOVONIX Announces Results of Engineering Study on Proprietary All-Dry, Zero-Waste Cathode Synthesis Process

Engineering report on NOVONIX’s proprietary cathode synthesis process highlights potential improvements over conventional cathode synthesis:Capital expense intensity estimated nearly 30% lower Processing cost reductions estimated nearly 50% lower Estimated power consumption improvements of approximately 25% Removes the need for water in the material processing steps Eliminates other key waste byproducts including sodium sulphate (Na2SO4)BRISBANE, Australia, Sept. 12, 2023 (GLOBE NEWSWIRE) — NOVONIX Limited (NASDAQ: NVX, ASX: NVX) (“NOVONIX” or the “Company”), a leading battery materials and technology company, announced today that Hatch Ltd., a global engineering consultancy firm, has delivered its report that evaluates NOVONIX’s revolutionary all-dry, zero-waste cathode synthesis process (“NOVONIX process”) with potentially...

Continue reading

NanoXplore Reports Record Results in Q4 and Full year 2023

MONTREAL, Sept. 11, 2023 (GLOBE NEWSWIRE) — NanoXplore Inc. (“NanoXplore” or “the Corporation”) (TSX: GRA and OTCQX: NNXPF), a world-leading graphene company, reported today financial results for the year ended June 30, 2023. All amounts in this press release are in Canadian dollars, unless otherwise stated. HIGHLIGHTSHigher total revenues of $33.3M in Q4-2023 compared to $28.3M in Q4-2022, representing an 18% increase, and total revenues of $123.9M in 2023 compared to $94.3M in 2022, representing a 31% increase; Gross margin on revenues from customers of 20.8% in Q4-2023 compared to 16.8% in Q4-2022 and of 17.4% during the year 2023 compared to 10.2% in 2022; Record adjusted EBITDA* of $1.1M for the advanced materials, plastics and composite products segment offset by -$0.6M for the battery cells segment (VoltaXplore initiative)...

Continue reading

Humacyte to Announce Top Line Data from Phase 2/3 V005 Trial in Vascular Trauma Evaluating its Human Acellular Vessel™ (HAV™) Tuesday, September 12, 2023 at 8:00 AM ET

Virtual Webinar to Include Key Opinion Leader Perspectives on the Potential of the HAV in Vascular Trauma Repair DURHAM, N.C., Sept. 11, 2023 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, will host a virtual webinar to announce top line data results from its Phase 2/3 V005 vascular trauma clinical trial. The V005 trial evaluated the HAV, an off-the-shelf, universally implantable bioengineered human tissue, in vascular trauma repair. The event will also feature Dr. Michael Curi (Rutgers University), who will discuss the unmet clinical need in vascular trauma, and the use of the HAV as a potential repair solution for patients and soldiers with limb- and life-threatening injuries. Dr. Curi has utilized...

Continue reading

Finning to host Investor Day on September 26, 2023

VANCOUVER, British Columbia, Sept. 11, 2023 (GLOBE NEWSWIRE) — Finning International Inc. (TSX: FTT) (“Finning”) will host its Investor Day on September 26, 2023 in Antofagasta, Chile. A video webcast of the Investor Day and the presentation slides will be available on our website. The event will start at 7:30 AM Eastern Time and is expected to last for about three hours. To participate in our 2023 Investor Day virtually, please register for the webcast. The Investor Day will feature presentations by members of our leadership team providing an update on our strategy with a focus on showcasing our South American business. Following the presentations, participants will have an opportunity to ask questions. If you are joining virtually, please use the Q&A function on the webcast portal. The video webcast and the presentation...

Continue reading

ArrowMark Financial Corp. Announces an Increase in the Third Quarter 2023 Cash Distribution to $0.45 Per Share

DENVER, Colo., Sept. 11, 2023 (GLOBE NEWSWIRE) — ArrowMark Financial Corp., (NASDAQ: BANX) (“ArrowMark Financial” or the “Fund”), today announced that its Board of Directors increased the quarterly cash distribution to $0.45 per share from $0.39 per share, an increase of $0.06 from the previous recurring quarterly rate. Earnings have benefited from the Fund’s meaningful exposure to floating rate assets, at approximately 86%, and a higher asset base. While the rising rate environment has buoyed earnings, the Fund had entered its third year of consistently exceeding the previous declared distributions. This has allowed the Fund to deliver on its objective to provide shareholders with current income. “We are very pleased to announce net income for Q2 2023 was $0.62 per share, well in excess of the previous quarterly distribution...

Continue reading

SEACOR Marine Announces Comprehensive Refinancing Transaction

HOUSTON, Sept. 11, 2023 (GLOBE NEWSWIRE) — SEACOR Marine Holdings Inc. (NYSE: SMHI) (the “Company” or “SEACOR Marine”), a leading provider of marine and support transportation services to offshore energy facilities worldwide, today announced that it has entered into a new $122.0 million senior secured term loan with certain affiliates of EnTrust Global (the “SMFH Credit Facility”) providing the Company with a more efficient and consolidated capital structure. The proceeds from the SMFH Credit Facility will be used, among other things, to refinance $104.6 million of principal indebtedness under five separate debt facilities with different lenders thereby extending their maturity dates from 2023-2026 to 2028. Borrowings under the SMFH Credit Facility will bear interest at a rate of 11.75% per annum and principal will be repaid in...

Continue reading

Attend the NEC X FutureFusion Forum – A Collaborative Initiative for Silicon Valley’s Tech Startup Ecosystem

September 14ᵗʰ event brings together entrepreneurs, investors and startups with keynotes from MIT, panel discussions on AI and pitch presentations from emerging tech startups PALO ALTO, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) — Members of the press are invited to attend the FutureFusion Forum, which brings together high-tech and artificial intelligence (AI) industry leaders that are disrupting the world with tech-driven innovation. Experts will be available by appointment to discuss today’s most pressing issues in AI technology and the startup ecosystem.WHAT:   The FutureFusion Forum is open to any media that would like to attend.WHEN:   September 14th from 9am-5pm pacific time (or any block of time you can make it).WHERE:   Hyatt Centric Mountain View, Calif., Cloud Ballroom, 2nd floor.WHO:   FutureFusion Forum is...

Continue reading

Axis Provides Business Update and Announces Closing of $2.67 Million Private Placement of Unsecured Subordinated Debentures

TORONTO, Sept. 11, 2023 (GLOBE NEWSWIRE) — Axis Auto Finance Inc. (“Axis” or the “Company“) [TSX: AXIS], a financial technology company changing the way Canadians purchase and finance used vehicles, is pleased to provide a business update and announce the closing of a private placement (the “Private Placement“) of unsecured subordinated debentures (the “Debentures“). Business Update Over the last 12 months, elevated inflation levels, supply chain disruption and rapidly rising interest rates have created challenges in the non-prime auto finance market. Inflation resulted in more borrower defaults leading to higher credit loss rates, supply chain issues affected vehicle availability as well as affordability and rising interest rates increased borrowing costs. Axis has responded to these...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.